Precigen Inc (PGEN)

0.9435 +0.01 (+0.67%) USD  |  NASDAQ  |  Mar 24, 14:17
More

Precigen News

News

Headline
Wire
Time (ET)
Precigen eases fears of exposure to Silicon Valley Bank crisis
SA Breaking News
03/13 06:34
CARA and DOMO among mid-day movers
SA Breaking News
03/07 12:39
CDTX, PTGX and TAST among premarket gainers
SA Breaking News
03/07 08:38
Precigen Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
Yahoo
03/06 16:05
Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response
Yahoo
02/07 08:00
Insider Buy: Precigen
MT Newswires
01/31 16:08
Germantown's Precigen raises $75M to advance treatments for rare diseases
Yahoo
01/30 14:34
--Cantor Fitzgerald Adjusts Price Target on Precigen to $10 From $7, Maintains Overweight Rating
MT Newswires
01/30 10:34
Precigen Closes $75 Million Common Stock Offering
MT Newswires
01/30 04:27
Sector Update: Health Care Stocks Largely Sit Out Late Market Rebound
MT Newswires
01/25 16:09
Top Midday Decliners
MT Newswires
01/25 14:03
GMBL, THMO and HLBZ among mid-day movers
SA Breaking News
01/25 12:59
Sonoma, First Wave top healthcare gainers; Precigen, Baudax Bio among losers
SA Breaking News
01/25 10:00
Precigen slumps ~15% on pricing $75M common stock offering
SA Breaking News
01/25 05:40
Precigen Prices $75 Million Common Stock Offering
MT Newswires
01/25 03:20
Precigen Announces Pricing of $75.0 Million Public Offering of Common Stock
PR Newswire
01/24 22:40
Precigen Announces Proposed $75.0 Million Public Offering of Common Stock
PR Newswire
01/24 16:05
Precigen Announces Positive Phase 1 Dose Escalation and Expansion Cohort Data for Investigational Off-the-Shelf PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis
PR Newswire
01/24 16:01
Catalyst watch: Tesla reverberations, Intel earnings, Rocket Lab launch and Macau stocks on holiday
SA Breaking News
01/20 14:30
Precigen Provides Pipeline and Corporate Updates at the 41st Annual J.P. Morgan Healthcare Conference
PR Newswire
01/11 18:45
Precigen to Host a Virtual R&D Event on January 24th to Share Safety and Efficacy Data from the Phase 1 Dose Escalation and Expansion Cohorts of PRGN-2012 AdenoVerse™ Immunotherapy in Recurrent Respiratory Papillomatosis
PR Newswire
01/04 16:05
Precigen’s Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
Yahoo
12/27 08:00
Precigen to Present at the 41st Annual J.P. Morgan Healthcare Conference
PR Newswire
12/19 16:05
Precigen posts Phase 1 data for CAR-T therapy in blood cancer
SA Breaking News
12/13 07:12
Precigen Says Leukemia Therapeutic Candidate Shows Positive Clinical Responses During Study
MT Newswires
12/13 04:04
Precigen Announces Positive Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T® Manufactured Overnight for Next Day Infusion in Relapsed or Refractory Acute Myeloid Leukemia Patients
PR Newswire
12/12 19:01
--Cantor Fitzgerald Starts Precigen at Overweight With $7 Price Target
MT Newswires
11/18 09:31
Precigen GAAP EPS of -$0.04 beats by $0.10, revenue of $16.72M beats by $14M
SA Breaking News
11/09 16:13
Precigen Reports Third Quarter 2022 Financial Results and Progress of Clinical Programs
PR Newswire
11/09 16:05
Precigen to Announce Third Quarter 2022 Financial Results on November 9th
PR Newswire
11/02 16:30
--Precigen Appoints Rutul Shah as Its First Chief Operating Officer, Effective Oct. 1
MT Newswires
09/21 16:40
Precigen Names Rutul R. Shah Chief Operating Officer
PR Newswire
09/21 16:30
Precigen to Participate in the 2022 Wells Fargo Healthcare Conference
PR Newswire
09/01 08:05
Precigen Closes Sale of Non-Healthcare Unit Trans Ova Genetics
MT Newswires
08/22 10:59
Precigen Completes Sale of Non-Healthcare Subsidiary Trans Ova Genetics
PR Newswire
08/22 08:05
Insider Sell: Precigen
MT Newswires
08/16 07:59
Shares of Precigen rise ~13% after co reports a Q2 bottom line beat
SA Breaking News
08/09 15:16
--HC Wainwright Adjusts Precigen's Price Target to $6 from $10, Keeps Buy Rating
MT Newswires
08/09 08:49
-- Earnings Flash (PGEN) PRECIGEN Reports Q2 Revenue $2.91M
MT Newswires
08/08 16:20
Notable earnings after Monday's close
SA Breaking News
08/07 17:35
Thinking about buying stock in Exela Technologies, Tyme Technologies, Carnival Corp, Precigen, or Akerna?
PR Newswire
07/05 10:55
Precigen To Sell Trans Ova Genetics Unit For $170 Million; Shares Climb
MT Newswires
07/05 10:34
Precigen to sell Trans Ova Genetics for $170M upfront
SA Breaking News
07/05 09:10
Precigen Enters into Agreement to Divest Non-Healthcare Subsidiary Trans Ova Genetics
PR Newswire
07/05 08:05
Precigen to Participate in the Stifel 2022 Virtual Cell Therapy Summit
PR Newswire
06/27 16:05
Precigen to Participate in the 2022 H.C. Wainwright Global Investment Conference
PR Newswire
05/17 16:05
-- Earnings Flash (PGEN) PRECIGEN Reports Q1 Revenue $32M, vs. Street Est of $23.3M
MT Newswires
05/09 16:39
Precigen Reports First Quarter 2022 Financial Results and Business Updates
PR Newswire
05/09 16:05
Precigen's Acute Myeloid Leukemia Treatment Candidate Gets FDA Fast Track Designation
MT Newswires
04/04 11:04
SERA, PGEN and CNTB among after hour movers
SA Breaking News
03/18 17:41
-- Earnings Flash (PGEN) PRECIGEN Reports Q4 Revenue $24.2M, vs. Street Est of $22.2M
MT Newswires
03/01 08:02
Precigen provides pipeline updates for 2022
SA Breaking News
01/12 16:55
Precigen Provides Pipeline and Corporate Updates at the 40th Annual J.P. Morgan Healthcare Conference
PR Newswire
01/12 16:30
Precigen to Present at the 40th Annual J.P. Morgan Healthcare Conference
PR Newswire
01/05 16:05
Precigen interim early-stage data on AML therapy shows 50% objective response rate
SA Breaking News
12/13 17:53
Precigen Announces Positive Interim Phase 1 Data for PRGN-3006 UltraCAR-T® in Relapsed or Refractory Acute Myeloid Leukemia
PR Newswire
12/13 17:05
Insider Buy: Precigen
MT Newswires
11/30 17:06
Precigen gains 9% as Director buy 1M shares
SA Breaking News
11/24 14:55
Insider Buy: Precigen
MT Newswires
11/24 06:00
Precigen to Present at the Stifel 2021 Virtual Healthcare Conference
PR Newswire
11/10 16:05
Precigen Achieves Significant Clinical Progress for UltraCAR-T® and AdenoVerse™ Therapies
PR Newswire
11/04 09:15
Catalyst watch for next week: FOMC and OPEC meetings, Beyond Meat hits McDonald's stores and more eyes on crypto
SA Breaking News
10/29 15:00
Precigen to Host R&D Update Virtual Event on November 4th to Share Clinical Developments
PR Newswire
10/27 16:38
Precigen Gets FDA Nod to Begin Early-Stage PRGN-3007 Trial in Hematological, Solid Tumors
MT Newswires
10/26 13:54
Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for PRGN-3007 UltraCAR-T® in Advanced ROR1+ Hematological and Solid Tumors
PR Newswire
10/26 08:05
Precigen Appoints CFO
MT Newswires
10/12 10:16
Precigen Appoints Harry Thomasian Jr. as Chief Financial Officer
PR Newswire
10/12 08:05
Precigen Releases Additional Type 1 Diabetes Treatment Trial Data, Sees Potential as 'Standalone Therapy'
MT Newswires
10/01 09:44
Precigen ActoBio Announces Additional Positive Interim Data from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes
PR Newswire
10/01 08:05
Meet members of the 2021 IPO class: life sciences tools (part 1)
SA Breaking News
09/29 12:07
Precigen to Present at the 2021 Wells Fargo Virtual Healthcare Conference and the H.C. Wainwright 23rd Annual Global Investment Conference
PR Newswire
09/01 08:05
-- Earnings Flash (PGEN) PRECIGEN Reports Q2 Revenue $33.6M, vs. Street Est of $21.1M
MT Newswires
08/09 16:04
Precigen Reports Second Quarter and First Half 2021 Financial Results
PR Newswire
08/09 16:01
Precigen to Announce Second Quarter and First Half 2021 Financial Results on August 9th
PR Newswire
08/02 16:05
XBIT, IMMR, ODT and INSG among after-hours movers
SA Breaking News
07/06 17:32
After Hours Watch List Scorecard: PGEN, TYME, VRTX
MT Newswires
06/11 16:33
Stocks Retreat Midday Amid Inflation Worries
MT Newswires
06/11 13:06
Midday Report: Wall Street Retreats Midday Amid Inflation Worries
MT Newswires
06/11 12:56
Wall Street Steady Pre-Bell, Long-Term Inflation Worries Fade
MT Newswires
06/11 09:16
Sector Update: Health Care Stocks Slipping Ahead of Friday's Market Open
MT Newswires
06/11 09:16
Hot Stocks: Tesla makes Plaid sexy, big drug development moves, PLAY gets play
SA Breaking News
06/11 09:06
US Futures in Holding Pattern, Long-Term Inflation Worries Fade
MT Newswires
06/11 08:34
Thinking about buying stock in Novan, Chemomab Therapeutics, Precigen, ChemoCentryx, or Senseonics?
PR Newswire
06/11 08:30
Precigen soars 28% on positive AG019 Actobiotics data in type 1 diabetes
SA Breaking News
06/11 08:28
Update: Precigen Soars in Pre-Market Trading After Reporting Positive Topline Results in Type 1 Diabetes Trial
MT Newswires
06/11 05:54
MT Newswires After Hours Watch List: PGEN, TYME, VRTX
MT Newswires
06/10 17:58
Precigen Reports Positive Topline Results in Type 1 Diabetes Trial -- Stock Jumps 29% After-Hours
MT Newswires
06/10 17:21
Precigen ActoBio Announces Positive Topline Results from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes
PR Newswire
06/10 17:05
Precigen to Present at the JMP Securities Life Sciences Conference
PR Newswire
06/10 16:05
-- Earnings Flash (PGEN) PRECIGEN Posts Q1 Revenue $24.5M, vs. Street Est of $18.4M
MT Newswires
05/10 16:30
Precigen Reports First Quarter 2021 Financial Results
PR Newswire
05/10 16:30
Seeking Alpha Catalyst Watch
SA Breaking News
05/07 15:30
Precigen chief financial officer steps down
SA Breaking News
03/30 16:13
Precigen CFO Stepping Down April 2, Search Launched for Successor
MT Newswires
03/30 16:09
Precigen Announces Departure of Chief Financial Officer
PR Newswire
03/30 16:05
Precigen Doses First Patient in Early-Stage Study of Potential Vaccine For Respiratory Papillomatosis
MT Newswires
03/23 11:05
Precigen Announces First Patient Dosed for PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)
PR Newswire
03/23 08:05
Precigen Receives FDA Orphan Drug Designation to Treat Recurrent Respiratory Papillomatosis
MT Newswires
03/18 09:50
Precigen gets FDA orphan drug designation for PRGN-2012
SA Breaking News
03/18 08:42
Precigen Receives FDA Orphan Drug Designation for PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)
PR Newswire
03/18 08:30
--Analyst Actions: B. Riley Raises Precigen's Price Target to $14 from $10, Keeps Buy Rating
MT Newswires
03/02 08:55
Precigen Q4 Loss Narrows As Revenue Rises -- Stock Down 1% After-Hours
MT Newswires
03/01 16:53
-- Earnings Flash (PGEN) PRECIGEN Posts Q4 Revenue $19.3M, vs. Street Est of $21.2M
MT Newswires
03/01 16:11
Precigen EPS misses by $0.07, misses on revenue
SA Breaking News
03/01 16:07
Precigen Reports Fourth Quarter and Full Year 2020 Financial Results
PR Newswire
03/01 16:05
--Analyst Actions: Stifel Initiates Coverage on Precigen With Buy Rating, Sets Price Target at $13
MT Newswires
02/25 09:31
Precigen to Announce Fourth Quarter and Full Year 2020 Financial Results on March 1st
PR Newswire
02/22 16:05
--Analyst Actions: Wells Fargo Starts Precigen at Overweight With $14 Price Target
MT Newswires
02/22 08:49
--Analyst Actions: B. Riley Starts Precigen at Buy with $10 Price Target
MT Newswires
02/18 08:56
Cell therapy biotech Vor Biopharma prices upsized IPO at $18/share, trades today
SA Breaking News
02/05 06:58
Precigen to Participate in Guggenheim Healthcare Talks Oncology Day
PR Newswire
02/04 16:05
Precigen announces closing of public offering raising $129.4M
SA Breaking News
01/26 16:17
Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
PR Newswire
01/26 16:05
VYNE Therapeutics, Evolus leads healthcare gainers; Neuronetics, Akerna among major losers
SA Breaking News
01/25 11:02
After Hours Watch List Scorecard: FLDM, SIVB, PGEN
MT Newswires
01/22 16:35
Sector Update: Health Care Stocks Sputter Late, Drift Back Near Friday Starting Marks
MT Newswires
01/22 16:00
Sector Update: Slim Advance for Health Care Stocks Amid Biotech Rebound
MT Newswires
01/22 13:19
Precigen Prices $112.5 Million Public Offering of Shares at $7.50 Each
MT Newswires
01/22 09:26
Wall Street Set to Open in Red Territory as China Grapples With New Virus Outbreaks
MT Newswires
01/22 09:19
IBM, GSAT among premarket losers
SA Breaking News
01/22 08:29
Precigen announces pricing of $112.5M public offering
SA Breaking News
01/22 08:13
Precigen Announces Pricing of $112.5 Million Public Offering of Common Stock
PR Newswire
01/22 08:05
MT Newswires After Hours Watch List: FLDM, SIVB, PGEN
MT Newswires
01/21 17:53
SWIR, PGEN, GSL and FLDM among after-hours movers
SA Breaking News
01/21 17:51
Precigen Starts Common Stock Offering; Shares Down After-Hours
MT Newswires
01/21 16:26
Precigen under pressure on proposed public offering
SA Breaking News
01/21 16:05
Precigen Announces Proposed Public Offering of Common Stock
PR Newswire
01/21 16:01
Precigen announces positive preliminary data from early-stage PRGN-2009 cancer study
SA Breaking News
01/13 16:51
Precigen Provides Pipeline Updates at the 39th Annual J.P. Morgan Healthcare Conference
PR Newswire
01/13 16:05
Precigen to Present at the 39th Annual J.P. Morgan Healthcare Conference
PR Newswire
01/06 08:05
Precigen Wins FDA OK For Phase 1 Trial of Respiratory Papillomatosis Drug Candidate
MT Newswires
01/05 09:02
Precigen on go with Phase I study of PRGN-2012 in respiratory papillomatosis
SA Breaking News
01/05 08:53
Precigen Announces Clearance of IND to Initiate Phase I Study of PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)
PR Newswire
01/05 08:05
--Analyst Actions: HC Wainwright Adjusts Precigen's Price Target to $10 From $8, Keeps at Buy
MT Newswires
12/16 09:28
Precigen Provides Latest Clinical Developments at Virtual R&D Update Event
PR Newswire
12/15 19:37
MVIS, PGEN, SLDB and AMWL among midday movers
SA Breaking News
12/15 12:40
Precigen to Host R&D Update Virtual Event on December 15th to Share Latest Clinical Developments
PR Newswire
12/08 16:05
Precigen Presents New Data Supporting the Safety, Clinical Activity, Expansion and Persistence of PRGN-3006 UltraCAR-T® at the 62nd ASH Annual Meeting and Exposition
PR Newswire
12/07 10:05
Precigen Inc. f/k/a/ Intrexon Corporation: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
Globe Newswire
12/04 08:00
PGEN DEADLINE TOMORROW: Hagens Berman, National Trial Attorneys, Alerts Precigen, Inc. (PGEN) Investors to Application Deadline, Encourages Investors with Losses to Contact Its Attorneys
Globe Newswire
12/03 16:53
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Precigen, Inc. f/k/a Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline – PGEN
Globe Newswire
12/03 13:19
Zhang Investor Law Alerts Investors to December 4 Deadline in Securities Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation – PGEN, XON
Globe Newswire
12/03 10:40
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Precigen, Inc. f/k/a Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline - PGEN
PR Newswire
12/03 04:25
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON)
Globe Newswire
12/02 11:00
ROSEN, TOP RANKED AND TRUSTED INVESTOR COUNSEL, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important December 4 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourage Investors with Losses in Excess of $100K to Contact Firm - PGEN, XON
PR Newswire
12/01 23:59
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Precigen, Inc. (PGEN) Investors to December 4th Lead Plaintiff Deadline, Encourages Investors with Losses to Contact Its Attorneys
PR Newswire
12/01 14:42
PGEN, MESO & LOOP Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm
Globe Newswire
12/01 11:00
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Precigen, Inc. f/k/a Intrexon Corporation and Encourages Investors to Contact the Firm
Globe Newswire
11/30 20:00
PGEN 6-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Precigen, Inc. (PGEN) Investors with Losses to Contact Its Attorneys, Securities Fraud Deadline Approaching
Globe Newswire
11/28 13:16
UPCOMING DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon-- PGEN, XON
Globe Newswire
11/27 17:00
PGEN INVESTOR DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Precigen Inc., f/k/a Intrexon Corporation
PR Newswire
11/27 10:11
PGEN, MESO & LOOP Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm
Globe Newswire
11/25 11:00
AnPac Bio-Medical, Cocrystal Pharma leads healthcare gainers; Hepion Pharmaceuticals, Medigus among major losers
SA Breaking News
11/25 10:55
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Precigen, Inc. f/k/a Intrexon Corporation and Encourages Investors to Contact the Firm
Globe Newswire
11/24 18:00
DEADLINE ALERT for TCMD, CACC, ACB, PGEN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
11/24 11:00
PGEN LOOMING DEADLINE: Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against  Precigen, Inc. f/k/a Intrexon Corporation – PGEN, XON
Globe Newswire
11/24 10:18
PGEN CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Precigen Inc., f/k/a Intrexon Corporation     
Globe Newswire
11/24 09:16
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates LOOP, PGEN, TILE Investors on Approaching Securities Fraud Deadlines, Encourages Investors with Losses to Contact the Firm
Globe Newswire
11/23 15:12
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON)
Globe Newswire
11/23 12:00
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Precigen, Inc. f/k/a Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline – PGEN
Globe Newswire
11/22 00:23
ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important December 4 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $100K to Contact Firm – PGEN, XON
Globe Newswire
11/20 17:41
PGEN, XON IMPORTANT DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon-- PGEN, XON
Globe Newswire
11/19 10:58
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Precigen, Royal Caribbean, Mesoblast, and Loop Industries and Encourages Investors to Contact the Firm
Globe Newswire
11/18 17:00
PGEN CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Precigen Inc., f/k/a Intrexon Corporation  
Globe Newswire
11/17 17:05
DEADLINE ALERT for TCMD, CACC, ACB, PGEN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
11/17 12:30
PGEN IMMINENT DEADLINE: Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation – PGEN, XON
Globe Newswire
11/17 09:39
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Precigen, Inc. f/k/a Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline – PGEN
Globe Newswire
11/16 21:50
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Precigen, Inc. (PGEN), f/k/a Intrexon Corp. (XON) Investors with Losses to Contact Its Attorneys, Securities Fraud Action Filed, Important Deadline Approaching
Globe Newswire
11/16 16:49
DEADLINE ALERT for CACC, ACB, and PGEN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
11/16 11:30
Precigen's Clinical Partners Dose First Patients With UltraCAR-T Cells Manufactured Using UltraPorator System
MT Newswires
11/16 10:35
Precigen Announces Dosing of First Patients with UltraCAR-T® Cells Manufactured Using Proprietary UltraPorator™ System in Ongoing PRGN-3005 and PRGN-3006 Phase 1 Clinical Trials
PR Newswire
11/16 08:05
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON)
Globe Newswire
11/13 12:00
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important December 4 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $100K to Contact Firm - PGEN, XON
PR Newswire
11/12 20:05
SHAREHOLDER DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon- PGEN, XON; IMPORTANT DEADLINE –Precigen, Inc. f/k/a Intrexon Corporation– PGEN, XON
Globe Newswire
11/12 15:21
PGEN INVESTOR DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Precigen Inc., f/k/a Intrexon Corporation
PR Newswire
11/12 09:47
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Precigen, Inc. f/k/a Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline – PGEN
Globe Newswire
11/12 08:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Credit Acceptance Corporation, Precigen, Royal Caribbean, and Mesoblast and Encourages Investors to Contact the Firm
Globe Newswire
11/11 17:00
PGEN CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Precigen Inc., f/k/a Intrexon Corporation   
Globe Newswire
11/11 13:25
ACB & PGEN Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
Globe Newswire
11/11 11:00
DEADLINE ALERT for CACC and PGEN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
11/10 11:00
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Precigen, Inc. (PGEN), f/k/a Intrexon Corp. (XON) Investors with Losses to Contact Its Attorneys, Securities Fraud Action Filed, Important Deadline Approaching
Globe Newswire
11/09 16:07
DEADLINE ALERT for TCMD, CACC, ACB, PGEN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
11/09 12:00
Precigen Posts Narrower Q3 Loss, Higher Revenue
MT Newswires
11/09 10:26
Precigen EPS misses by $0.04, beats on revenue
SA Breaking News
11/09 08:15
-- Earnings Flash (PGEN) PRECIGEN Posts Q3 Revenue $23.6M, vs. Street Est of $17.7M
MT Newswires
11/09 08:05
Precigen Reports Third Quarter 2020 and Year-to-Date Financial Results
PR Newswire
11/09 08:05
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Precigen, Inc. f/k/a Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline – PGEN
Globe Newswire
11/08 03:03
ROSEN, A LEADING LAW FIRM, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important December 4 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $100K to Contact Firm – PGEN, XON
Globe Newswire
11/06 19:22
PGEN CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Precigen Inc., f/k/a Intrexon Corporation
Globe Newswire
11/06 16:28
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON)
Globe Newswire
11/06 11:30
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Precigen, Royal Caribbean, Mesoblast, and Loop Industries and Encourages Investors to Contact the Firm
Globe Newswire
11/04 18:00
DEADLINE ALERT for CACC, ACB, and PGEN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
11/04 11:00
Moore Kuehn, PLLC Encourages Investors of CLSN, PGEN or TCMD to Contact Law Firm
Globe Newswire
11/03 12:57
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Precigen, Inc. f/k/a Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline – PGEN
Globe Newswire
11/02 22:22
Precigen to Announce Third Quarter 2020 Financial Results on November 9th: Will host Pipeline and Data Update Call in Early December
PR Newswire
11/02 16:05
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates LOOP, PGEN, TCMD Investors on Securities Fraud Actions, Encourages Investors with Losses to Contact the Firm
Globe Newswire
11/02 13:33
DEADLINE ALERT for TCMD, CACC, ACB, PGEN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
11/02 12:00
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important December 4 Deadline in First Filed Securities Class Action Commenced by the Firm– PGEN, XON
Globe Newswire
10/30 16:58
PGEN CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Precigen Inc., f/k/a Intrexon Corporation
Globe Newswire
10/30 11:18
ROSEN, A LEADING LAW FIRM, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important December 4 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $100K to Contact Firm - PGEN, XON
PR Newswire
10/29 19:05
DEADLINE ALERT for CACC, ACB, and PGEN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
10/29 12:00
PGEN INVESTOR DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Precigen Inc., f/k/a Intrexon Corporation
PR Newswire
10/29 11:17
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Credit Acceptance Corporation, Precigen, Royal Caribbean, and Mesoblast and Encourages Investors to Contact the Firm
Globe Newswire
10/28 19:00
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Precigen, Inc. f/k/a Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline – PGEN
Globe Newswire
10/28 18:20
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Precigen, Inc. (PGEN), f/k/a Intrexon Corp. (XON) Investors with Losses to Contact Its Attorneys, Securities Fraud Action Filed, Application Deadline Approaching
Globe Newswire
10/26 17:35
Pomerantz Law Firm Announces the Filing of a Class Action against Precigen, Inc. f/k/a Intrexon Corporation Certain Officers - PGEN
PR Newswire
10/26 17:03
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – PGEN, XON
Globe Newswire
10/26 16:45
DEADLINE REMINDER: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON)
PR Newswire
10/26 12:30
DEADLINE ALERT for ACB and PGEN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
10/23 12:00
PGEN CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Precigen Inc., f/k/a Intrexon Corporation  
Globe Newswire
10/23 11:19
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Precigen, Inc (f/k/a Intrexon Corporation) - PGEN
Globe Newswire
10/21 19:26
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Aurora Cannabis, Credit Acceptance Corporation, Precigen, and Royal Caribbean and Encourages Investors to Contact the Firm
Globe Newswire
10/21 19:00
ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses Exceeding $100K to Contact the Firm – PGEN, XON
Globe Newswire
10/21 18:21
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON)
PR Newswire
10/21 12:00
PRECIGEN, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased Precigen, Inc.
PR Newswire
10/20 16:00
Moore Kuehn, PLLC Encourages Investors of PGEN or TCMD to Contact Law Firm
PR Newswire
10/20 09:13
Precigen Strengthens Focus on Strategic Partnerships and Names Gaurav Vij Head of Business Development
PR Newswire
10/20 07:30
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates PGEN, TCMD Investors, Encourages Investors with Losses to Contact Firm, Reminds of Critical Upcoming Deadlines
Globe Newswire
10/19 19:15
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Precigen, Inc (f/k/a Intrexon Corporation) - PGEN
Globe Newswire
10/17 16:22
PGEN CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Precigen Inc., f/k/a Intrexon Corporation
Globe Newswire
10/16 16:32
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON) Investors
PR Newswire
10/16 11:00
PGEN INVESTOR DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Precigen Inc., f/k/a Intrexon Corporation
PR Newswire
10/15 18:22
PRECIGEN, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased Precigen, Inc.
Globe Newswire
10/15 16:56
PGEN, GME, APHA and FSLY among midday movers
SA Breaking News
10/15 12:47
ROSEN, A LEADING AND LONGSTANDING FIRM, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important Deadline in Securities Class Action First Filed by the Firm – PGEN, XON
Globe Newswire
10/15 12:17
Organogenesis Holdings, Anavex Life Sciences leads healthcare gainers; Vertex Pharmaceuticals, Aphria among major losers
SA Breaking News
10/15 11:12
PGEN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Precigen, Inc. f/k/a Intrexon Corporation Shareholders of Class Action and Lead Plaintiff Deadline: December 4, 2020
Globe Newswire
10/15 11:00
FDA Clears Precigen's UltraPorator for Production of UltraCAR-T Cells in Clinical Trials
MT Newswires
10/15 08:22
FDA clears Precigen's UltraPorator for manufacturing UltraCAR-T cells in trials
SA Breaking News
10/15 08:11
Precigen's UltraPorator™ Receives FDA Clearance for Manufacturing UltraCAR-T® Cells in Clinical Trials
PR Newswire
10/15 07:30
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Precigen, Royal Caribbean, and Mesoblast and Encourages Investors to Contact the Firm
Globe Newswire
10/14 20:00
PGEN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Precigen, Inc. f/k/a Intrexon Corporation Shareholders of Class Action and Lead Plaintiff Deadline: December 4, 2020
PR Newswire
10/13 10:00
CACC, PGEN INVESTOR FRAUD ALERT: Hagens Berman, National Trial Attorneys, Updates CACC, PGEN Investors on Securities Class Actions, Encourages Investors with Losses to Contact Firm
Globe Newswire
10/12 17:53
ROSEN, A TOP RANKED LAW FIRM, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses in Excess of $100K to Contact the Firm -- PGEN, XON
PR Newswire
10/12 16:21
Sector Update: Health Care Stocks Add to Friday Advance After Other Sectors Fade
MT Newswires
10/09 15:56
Sector Update: Large Friday Gains for Health Care Stocks
MT Newswires
10/09 13:47
Midday Report: Wall Street Rises on Fresh Stimulus Hopes, Set for Weekly Gain
MT Newswires
10/09 12:50
PGEN, ACRX, MNK and FTV among midday movers
SA Breaking News
10/09 12:38
Precigen and Medigus lead Healthcare gainers; Mallinckrodt and GeoVax Labs lead losers
SA Breaking News
10/09 11:01
Precigen's Second-Largest Shareholder Merck KGaA Lifts Equity Stake Via Early Exercise of Convertible Note
MT Newswires
10/09 08:58
Merck KGaA raises stake in Precigen through convertible notes, Shares up 9%
SA Breaking News
10/09 08:09
Precigen Announces Merck KGaA, Darmstadt, Germany Increases Ownership Position Through Exercise of Convertible Note
PR Newswire
10/09 07:31
Portnoy Law: Lawsuit Filed On Behalf of Precigen, Inc. Investors
Globe Newswire
10/08 20:00
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, First Files Securities Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation - PGEN, XON
PR Newswire
10/08 19:33
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Precigen, Inc (f/k/a Intrexon Corporation) - PGEN
PR Newswire
10/08 18:16
Lt. General (Ret.) Thomas Bostick Appointed to CSX Corp. Board of Directors
Globe Newswire
10/08 09:00
PGEN INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages Precigen, Inc. (PGEN), f/k/a Intrexon Corp. (XON) Investors with Losses to Contact Its Attorneys, Securities Fraud Action Filed
Globe Newswire
10/07 18:19
PRECIGEN ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Precigen, Inc. f/k/a Intrexon Corporation and Encourages Investors to Contact the Firm
Globe Newswire
10/07 14:30
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Precigen, Inc. f/k/a Intrexon Corporation (PGEN; XON)
Globe Newswire
10/07 10:07
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Precigen, Inc. (PGEN), f/k/a Intrexon Corp. (XON) Investors with Losses to Contact Its Attorneys
PR Newswire
10/06 16:13